IRMD vs XOM · P/E 51, rev $42.4M vs P/E 24, rev $201.16B
Iradimed Co (IRMD) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Iradimed Co (IRMD) is a medical devices company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
Latest reported IRMD revenue for 2026-06-30 was $42.4M. Net income was $11.0M. Revenue was up 93.1% from 2026-03-31 to 2026-06-30. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
IRMD currently screens at market cap $1.19B and trailing P/E 50.9. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the IRMD and XOM stock pages for the full models.
Not investment advice.